Baseline ALBI Grade as an Independent Prognostic Factor of Survival in High-Risk Real-World HCC Under Atezolizumab–Bevacizumab
Journal of Hepatocellular Carcinoma · 2026-08 · Volume 13 · 1-12
DOI: 10.2147/jhc.s617103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-08. Verfasst von Filiz Araz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology, Başkent University Adana Dr. Turgut Noyan Training and Research Hospital, Adana, Türkiye. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastroenterology, Başkent University Adana Dr. Turgut Noyan Training and Research Hospital, Adana, Türkiye.
- Medical Oncology, Başkent University Adana Dr. Turgut Noyan Training and Research Hospital, Adana, Türkiye.
- Medical Oncology, University of Health Sciences, Adana City Training and Research Hospital, Adana, Türkiye.
- Medical Oncology, Adana City Training and Research Hospital, Adana, Türkiye.
- Radiology, Başkent University Adana Dr. Turgut Noyan Training and Research Hospital, Adana, Türkiye.
- Radiology, University of Health Sciences, Adana City Training and Research Hospital, Adana, Türkiye.
ORCID-Profile: Filiz Araz, Fatih Köse, Timuçin Çil, Berna Bozkurt Duman, Burcu Arslan Benli, Elif Karadeli, Okan Dilek
Zitieren
APA
Araz, F., Köse, F., Çil, T., Bozkurt Duman, B., Arslan Benli, B., Karadeli, E., & Dilek, O. (2026). Baseline ALBI Grade as an Independent Prognostic Factor of Survival in High-Risk Real-World HCC Under Atezolizumab–Bevacizumab. Journal of Hepatocellular Carcinoma, Volume 13, 1-12. https://doi.org/10.2147/jhc.s617103
Vancouver
Araz F, Köse F, Çil T, Bozkurt Duman B, Arslan Benli B, Karadeli E, et al. Baseline ALBI Grade as an Independent Prognostic Factor of Survival in High-Risk Real-World HCC Under Atezolizumab–Bevacizumab. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-12. doi:10.2147/jhc.s617103
BibTeX
@article{Araz2026,
author = {Araz, Filiz and Köse, Fatih and Çil, Timuçin and Bozkurt Duman, Berna and Arslan Benli, Burcu and Karadeli, Elif and Dilek, Okan},
title = {Baseline ALBI Grade as an Independent Prognostic Factor of Survival in High-Risk Real-World HCC Under Atezolizumab–Bevacizumab},
journal = {Journal of Hepatocellular Carcinoma},
year = {2026},
volume = {Volume 13},
pages = {1--12},
doi = {10.2147/jhc.s617103}
}
EUVIMED